
|Videos|December 15, 2020
Oral Semaglutide: Cardiovascular Outcomes, Safety, and Tolerability
The safety profile of oral semaglutide across the PIONEER trials was shown to be consistent with other glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Click PLAY to watch the video abstract.
Click
Click
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Latest CME
Trending on AJMC
1
FDA to Accept De-Identified Real-World Evidence for Select Medical Device Applications
2
FDA Approves Once-Monthly PCSK9 Injection for LDL-C Reduction
3
Bispecifics in New Combos, New Uses, and Earlier Lines of Treatment in Myeloma
4
COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants
5





































